Web Results

Vinblastine - Wikipedia


Vinblastine is a chemotherapy medication, typically used with other medications, to treat a number of types of cancer. This includes Hodgkin's lymphoma, ...

Vinblastine - Chemotherapy Drugs - Chemocare


(vin-BLAST-een). Trade names: Alkaban-AQ®, Velban®. Other names: Vinblastine Sulfate, Vincaleukoblastine, VLB. Vinbastine is the generic name for the ...

Vinblastine (Velbe) | Cancer Research UK


Jul 24, 2015 ... Read about the cancer treatment drug vinblastine, also called Velbe, including what it is, how it works and possible side effects.

Vinblastine: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for vinblastine. Includes indications, proper use, special instructions, precautions, and possible side effects.

Vinblastine: MedlinePlus Drug Information


Jun 15, 2013 ... Vinblastine: learn about side effects, dosage, special precautions, and more on MedlinePlus.

vinblastine | C46H58N4O9 - PubChem


Vinblastine is a natural alkaloid isolated from the plant Vinca rosea Linn. Vinblastine binds to tubulin and inhibits microtubule formation, resulting in disruption of ...

vinblastine intravenous : Uses, Side Effects, Interactions, Pictures ...


Find patient medical information for vinblastine intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ...

Vinblastine (Velbe ®) - Cancer Information - Macmillan Cancer ...


Find out about Vinblastine (Velbe ®), which is a chemotherapy drug used to treat different cancers including lymphomas, bladder, breast and testicular cancer, ...

Vinblastine - DrugBank


Jun 13, 2005 ... Vinblastine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death.

Velban (vinblastine) dosing, indications, interactions, adverse effects ...


Medscape - Indication-specific dosing for Velban (vinblastine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...